在中国成都多药耐药结核病患者的药物相关负担的潜形状分析和影响因素
Yuanyuan Li1, Qiaolin Yu1, Rong Yao2
1The First Department of Tuberculosis, the Public Health Clinical Center of ChengDu, Chengdu, Sichuan, People's Republic of China.
Patient preference and adherence
|November 10, 2025
概括
耐多药结核病 (MDR-TB) 患者经历不同的药物负担. 识别这些个人资料和影响诸如健康素养和日常干扰等因素是个性化患者护理和改善患者遵守的关键.
科学领域:
- 公共卫生 公共卫生
- 传染性疾病 传染性疾病
- 患者报告的结果
背景情况:
- 多药耐药结核病 (MDR-TB) 治疗存在重大挑战,原因是持续时间长,治疗方案复杂.
- 这种复杂性往往导致与药物相关的大量负担,对患者的坚持和生活质量产生负面影响.
- 关于这种负担及其决定因素在MDR-TB患者中异质性的研究有限.
研究的目的:
- 在MDR-TB患者中识别与药物相关负担的明显隐性概况.
- 检查与每个已识别的个人资料相关的特征和影响因素.
- 为制定定制干预策略提供证据,以减轻药物负担.
主要方法:
- 便利抽样从第三级传染病医院招募了214名MDR-TB患者.
- 通过调查问卷收集的数据,包括药物生存问卷 (LMQ) 和健康素养管理量表 (HeLMS).
- 隐性概况分析 (LPA) 确定了负担概况;多变量后勤回归探索了相关因素.
主要成果:
- 结果显示有两种情况:C1 - 负担较低 (44%) 和C2 - 负担较高 (56%).
- 低负担概况与较少的副作用,没有护理人员和更高的健康素养有关.
- 高负担概况与高等教育,更长的治疗时间和离治疗中心更远的距离有关.
结论:
- 在MDR-TB患者中,与药物相关的负担是异质的.
- 分层管理和个性化干预,考虑到诸如健康素养和日常干扰等因素,至关重要.
- 解决这些因素可以帮助减轻药物负担并改善患者的治疗结果.
相关概念视频
Pulmonary Tuberculosis V
530
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
530
Pulmonary Tuberculosis I
816
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
816
Pulmonary Tuberculosis IV
469
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
469
Therapeutic Drug Monitoring: Affecting Factors
189
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
189


